par van der Burg, Maria;Griffin, Clare L;Guthrie, David;Lamont, Alan;Jayson, Gordon C;Kristensen, Gunnar;Mediola, César;Coens, Corneel;Qian, Wendi;Parmar, Mahesh K B;Swart, Anne Marie;MRC OV05, Pascal;EORTC 55955 investigators, ;Rustin,
Référence Lancet, 376, 9747, page (1155-1163)
Publication Publié, 2010-10
Référence Lancet, 376, 9747, page (1155-1163)
Publication Publié, 2010-10
Article révisé par les pairs
Titre: |
|
Auteur: | van der Burg, Maria; Griffin, Clare L; Guthrie, David; Lamont, Alan; Jayson, Gordon C; Kristensen, Gunnar; Mediola, César; Coens, Corneel; Qian, Wendi; Parmar, Mahesh K B; Swart, Anne Marie; MRC OV05, Pascal; EORTC 55955 investigators, ; Rustin, |
Informations sur la publication: | Lancet, 376, 9747, page (1155-1163) |
Statut de publication: | Publié, 2010-10 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Adult |
Aged | |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
CA-125 Antigen -- blood | |
Carcinoma -- diagnosis -- drug therapy -- immunology | |
Drug Administration Schedule | |
Early Detection of Cancer | |
Europe | |
Evidence-Based Medicine | |
Female | |
Follow-Up Studies | |
Humans | |
Kaplan-Meier Estimate | |
Middle Aged | |
Neoplasm Recurrence, Local -- diagnosis -- drug therapy -- immunology | |
Ovarian Neoplasms -- diagnosis -- drug therapy -- immunology | |
Platinum Compounds -- administration & dosage | |
Quality of Life | |
Questionnaires | |
Russia | |
South Africa | |
Time Factors | |
Treatment Outcome | |
Tumor Markers, Biological -- blood | |
Note générale: | Comparative Study |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0140-6736 |
info:doi/10.1016/S0140-6736(10)61268-8 | |
info:pii/S0140-6736(10)61268-8 | |
info:pmid/20888993 |